Pyxis Oncology holds special stockholder meeting
PYXS•Pyxis Oncology shareholders approved doubling authorized common stock to 380 million shares from 190 million at a November 13 special meeting. The charter amendment took effect upon filing that day.
1. Share increase approved
Shareholders approved increasing Pyxis Oncology’s authorized common stock from 190 million to 380 million shares at the November 13, 2026, special meeting. The charter amendment took effect upon filing on November 13. Shareholders also authorized adjournments to solicit additional proxies if needed, but no adjournment was necessary.
